Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial.
about
Docetaxel in prostate cancer: a familiar face as the new standard in a hormone-sensitive setting.The STAMPEDE trial: paradigm-changing data through innovative trial design.Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial.Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations.Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.Whole pelvis radiotherapy for pathological node-positive prostate cancer : Oncological outcome and prognostic factors.Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer.[Which patients with localized prostate cancer benefit from which local procedure and what does "benefit" mean in prostate cancer?]Prostate cancer: 'The prostate' in patients with metastatic prostate cancer: to treat or not to treat?Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer: A Comprehensive Review.
P2860
Q33656791-3F704466-0695-4FA4-989B-69B925322FC1Q36163344-5BEF0317-096C-478C-B696-C7B0AD5EB68BQ36707077-71DA387E-061D-4BB5-8C7B-138C04EB23ECQ38744286-321F4ACD-C936-44F5-B81A-CB0E34BAF6BCQ38977428-09EDDC6F-CBA6-4FD9-831A-18CF10EBDB02Q40173819-BB429514-4FF0-4E5F-9F2F-DAB033FB448DQ40374061-EE175969-F950-4C63-B726-FEC82B6975B1Q45198533-505CCF60-85B3-4651-83B6-451EC8852532Q49630878-D470D71B-D1D3-4996-97DA-FE70E5059B1BQ53835461-D64F9A64-29B8-4657-952A-109B9964EFF0Q55379783-11AE7DB4-DE0A-4C08-8CAA-1B6047EAF9F0
P2860
Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial.
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Failure-Free Survival and Radi ...... rol Arm of the STAMPEDE Trial.
@ast
Failure-Free Survival and Radi ...... rol Arm of the STAMPEDE Trial.
@en
type
label
Failure-Free Survival and Radi ...... rol Arm of the STAMPEDE Trial.
@ast
Failure-Free Survival and Radi ...... rol Arm of the STAMPEDE Trial.
@en
prefLabel
Failure-Free Survival and Radi ...... rol Arm of the STAMPEDE Trial.
@ast
Failure-Free Survival and Radi ...... rol Arm of the STAMPEDE Trial.
@en
P2093
P2860
P50
P1433
P1476
Failure-Free Survival and Radi ...... rol Arm of the STAMPEDE Trial.
@en
P2093
Alastair W S Ritchie
Alison Birtle
Christopher C Parker
David Matheson
David P Dearnaley
Delia Pudney
Francesca Schiavone
Isabel Syndikus
J Martin Russell
Jan Wallace
P2860
P304
P356
10.1001/JAMAONCOL.2015.4350
P577
2015-11-25T00:00:00Z